{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:07:40Z","timestamp":1780096060548,"version":"3.54.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["71591"],"award-info":[{"award-number":["71591"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13760-024-02586-x","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:02:31Z","timestamp":1720594951000},"page":"1655-1662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis"],"prefix":"10.1007","volume":"124","author":[{"given":"Elyar","family":"Sadeghi Hokmabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-0748","authenticated-orcid":false,"given":"Amin","family":"Daei Sorkhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aila","family":"Sarkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Sadigh-Eteghad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mehdizadehfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Sadeghpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Farhoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"3","key":"2586_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35(3):664\u2013670","journal-title":"Stroke"},{"issue":"2","key":"2586_CR2","first-page":"335","volume":"20","author":"C Bushnell","year":"2014","unstructured":"Bushnell C, Saposnik G (2014) Evaluation and management of cerebral venous thrombosis. Continuum (Minneapolis, Minn) 20(2):335\u2013351","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"16","key":"2586_CR3","doi-asserted-by":"publisher","first-page":"e2200","DOI":"10.1212\/WNL.0000000000010598","volume":"95","author":"FO Otite","year":"2020","unstructured":"Otite FO, Patel S, Sharma R, Khandwala P, Desai D, Latorre JG, Akano EO, Anikpezie N, Izzy S, Malik AM et al (2020) Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States. Neurology 95(16):e2200\u2013e2213","journal-title":"Neurology"},{"issue":"2","key":"2586_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","volume":"6","author":"MG Bousser","year":"2007","unstructured":"Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6(2):162\u2013170","journal-title":"Lancet Neurol"},{"issue":"2","key":"2586_CR5","first-page":"117","volume":"117","author":"M Janghorbani","year":"2008","unstructured":"Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E (2008) Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand 117(2):117\u2013121","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"2586_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000509802","volume":"83","author":"PS Idiculla","year":"2020","unstructured":"Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E (2020) Cerebral venous thrombosis: a comprehensive review. Eur Neurol 83(4):369\u2013379","journal-title":"Eur Neurol"},{"issue":"4","key":"2586_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American heart association\/American stroke association. Stroke 42(4):1158\u20131192","journal-title":"Stroke"},{"issue":"1","key":"2586_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ane.13506","volume":"145","author":"G Nepal","year":"2022","unstructured":"Nepal G, Kharel S, Bhagat R, Ka Shing Y, Ariel Coghlan M, Poudyal P, Ojha R, Sunder Shrestha G (2022) Safety and efficacy of direct oral anticoagulants in cerebral venous thrombosis: a meta-analysis. Acta Neurol Scand 145(1):10\u201323","journal-title":"Acta Neurol Scand"},{"key":"2586_CR9","doi-asserted-by":"publisher","first-page":"684638","DOI":"10.3389\/fphar.2021.684638","volume":"12","author":"R Roberti","year":"2021","unstructured":"Roberti R, Iannone LF, Palleria C, Curcio A, Rossi M, Sciacqua A, Armentaro G, Vero A, Manti A, Cassano V et al (2021) Direct oral anticoagulants: from randomized clinical trials to real-world clinical practice. Front Pharmacol 12:684638","journal-title":"Front Pharmacol"},{"key":"2586_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40495-020-00232-7","volume":"6","author":"J Rimsans","year":"2020","unstructured":"Rimsans J, Douxfils J, Smythe MA, Gosselin RC (2020) Overview and practical application of coagulation assays in managing anticoagulation with direct oral anticoagulants (DOACs). Curr Pharmacol Rep 6:241\u2013259","journal-title":"Curr Pharmacol Rep"},{"issue":"2","key":"2586_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/jcm7020029","volume":"7","author":"SA Joppa","year":"2018","unstructured":"Joppa SA, Salciccioli J, Adamski J, Patel S, Wysokinski W, McBane R, Al-Saffar F, Esser H, Shamoun F (2018) A practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents. J Clin Med 7(2):29. https:\/\/doi.org\/10.3390\/jcm7020029","journal-title":"J Clin Med"},{"issue":"1 pt A","key":"2586_CR12","first-page":"102017","volume":"49","author":"A Hajra","year":"2023","unstructured":"Hajra A, Ujjawal A, Ghalib N, Chowdhury S, Biswas S, Balasubramanian P, Gupta R, Aronow WS (2023) Expanding indications of nonvitamin k oral anticoagulants beyond nonvalvular atrial fibrillation and venous thromboembolism: a review of emerging clinical evidence. Curr Probl Cardiol 49(1 pt A):102017","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"2586_CR13","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1161\/STROKEAHA.122.039579","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Saldanha IJ, Misquith C, Zaidat B, Shah A, Joudi K, Persaud B, Abdul Khalek F, Shu L, de Havenon A et al (2022) Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke 53(10):3014\u20133024","journal-title":"Stroke"},{"issue":"10","key":"2586_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser MG, Canh\u00e3o P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I, Masuhr F et al (2017) European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2014endorsed by the european academy of neurology. Eur J Neurol 24(10):1203\u20131213","journal-title":"Eur J Neurol"},{"issue":"3","key":"2586_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5853\/jos.2022.01606","volume":"24","author":"P Klein","year":"2022","unstructured":"Klein P, Shu L, Nguyen TN, Siegler JE, Omran SS, Simpkins AN, Heldner M, Havenon A, Aparicio HJ, Abdalkader M et al (2022) Outcome prediction in cerebral venous thrombosis: the IN-REvASC score. J Stroke 24(3):404\u2013416","journal-title":"J Stroke"},{"issue":"3","key":"2586_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K et al (2022) Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke 53(3):728\u2013738","journal-title":"Stroke"},{"issue":"4","key":"2586_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thrombosis Haemost: JTH 3(4):692\u2013694","journal-title":"J Thrombosis Haemost: JTH"},{"issue":"7","key":"2586_CR18","doi-asserted-by":"publisher","first-page":"e2325283","DOI":"10.1001\/jamanetworkopen.2023.25283","volume":"6","author":"IB Riaz","year":"2023","unstructured":"Riaz IB, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, Houghton DE, Padrnos LJ, Shamoun FE, Wysokinski WE et al (2023) Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis. JAMA Netw Open 6(7):e2325283","journal-title":"JAMA Netw Open"},{"key":"2586_CR19","doi-asserted-by":"publisher","unstructured":"Bertoletti L, Gusto G, Khachatryan A, Quignot N, Chaves J, Moniot A, Mokgokong R (2022) Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: a nationwide comparative cohort study in France. Thromb haemost 122(8):1384\u20131396. https:\/\/doi.org\/10.1055\/a-1731-3922","DOI":"10.1055\/a-1731-3922"},{"issue":"8","key":"2586_CR20","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1161\/STROKEAHA.114.006167","volume":"45","author":"C Geisb\u00fcsch","year":"2014","unstructured":"Geisb\u00fcsch C, Richter D, Herweh C, Ringleb PA, Nagel S (2014) Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke 45(8):2469\u20132471","journal-title":"Stroke"},{"issue":"1","key":"2586_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12883-021-02091-1","volume":"21","author":"S Esmaeili","year":"2021","unstructured":"Esmaeili S, Abolmaali M, Aarabi S, Motamed MR, Chaibakhsh S, Joghataei MT, Mojtahed M, Mirzaasgari Z (2021) Rivaroxaban for the treatment of cerebral venous thrombosis. BMC Neurol 21(1):73","journal-title":"BMC Neurol"},{"issue":"1","key":"2586_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s13760-021-01651-z","volume":"122","author":"Z Bajko","year":"2022","unstructured":"Bajko Z, Maier S, Motataianu A, Filep RC, Stoian A, Andone S, Balasa R (2022) Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience. Acta Neurol Belg 122(1):105\u2013111","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"2586_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11239-021-02595-0","volume":"53","author":"L Pan","year":"2022","unstructured":"Pan L, Wang M, Zhou D, Ding Y, Ji X, Meng R (2022) Efficacy and safety of rivaroxaban in cerebral venous thrombosis: insights from a prospective cohort study. J Thromb Thrombolysis 53(3):594\u2013600","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"2586_CR24","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","volume":"76","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canh\u00e3o P, Karpov D, Nagel S, Posthuma L, Roriz JM et al (2019) Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol 76(12):1457\u20131465","journal-title":"JAMA Neurol"},{"key":"2586_CR25","doi-asserted-by":"publisher","unstructured":"Field TS, Dizonno V, Almekhlafi MA, Bala F, Alhabli I, Wong H, Norena M, Villaluna MK, King-Azote P, Ratnaweera N, Mancini S, Van Gaal SC, Wilson LK, Graham BR, Sposato LA, Blacquiere D, Dewar BM, Boulos MI, Buck BH, Odier C, \u2026 SECRET Investigators (2023) Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis. Stroke 54(11):2724\u20132736. https:\/\/doi.org\/10.1161\/STROKEAHA.123.044113","DOI":"10.1161\/STROKEAHA.123.044113"},{"key":"2586_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clineuro.2018.10.015","volume":"175","author":"R Shankar Iyer","year":"2018","unstructured":"Shankar Iyer R, Tcr R, Akhtar S, Muthukalathi K, Kumar P, Muthukumar K (2018) Is it safe to treat cerebral venous thrombosis with oral rivaroxaban without heparin? a preliminary study from 20 patients. Clin Neurol Neurosurg 175:108\u2013111","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"2586_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/25166085211046147","volume":"4","author":"TH Nguyen","year":"2021","unstructured":"Nguyen TH, Ngo TM, Phan BV, Pham BN, Dao NT, Nguyen AT, Nguyen TQ, Phan HT (2021) The novel oral anticoagulants (NOACs) for the treatment of cerebral venous thrombosis: a case study of 32 Vietnamese patients. J Stroke Med 4(2):105\u2013110","journal-title":"J Stroke Med"},{"issue":"4","key":"2586_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/STROKEAHA.119.028532","volume":"51","author":"D Aguiar de Sousa","year":"2020","unstructured":"Aguiar de Sousa D, Lucas Neto L, Arauz A, Sousa AL, Gabriel D, Correia M, Gil-Gouveia R, Penas S, Carvalho Dias M, Correia MA et al (2020) Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation. Stroke. 51(4):1174\u20131181","journal-title":"Stroke."},{"issue":"3","key":"2586_CR29","first-page":"1","volume":"5","author":"S Anticoli","year":"2016","unstructured":"Anticoli S, Pezzella F, Scifoni G, Ferrari C, Pozzessere C (2016) Treatment of cerebral venous thrombosis with rivaroxaban. J Biomed Sci 5(3):1\u20132","journal-title":"J Biomed Sci"},{"issue":"3","key":"2586_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s12028-021-01244-x","volume":"35","author":"JA Giles","year":"2021","unstructured":"Giles JA, Balasetti VKS, Zazulia AR (2021) Non-Vitamin K antagonist oral anticoagulants for the treatment of cerebral venous sinus thrombosis: a retrospective. Matched Cohort Analysis Neurocritical Care 35(3):783\u2013788","journal-title":"Matched Cohort Analysis Neurocritical Care"},{"issue":"1","key":"2586_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bjh.18177","volume":"198","author":"N Riva","year":"2022","unstructured":"Riva N, Galea F, Buhagiar I, Gatt A, Calleja-Agius J (2022) Efficacy and safety of the direct oral anti-coagulants in patients with cerebral vein thrombosis: a systematic review and meta-analysis. Br J Haematol 198(1):165\u2013182","journal-title":"Br J Haematol"},{"issue":"3","key":"2586_CR32","first-page":"235","volume":"105","author":"C Christersson","year":"2019","unstructured":"Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M et al (2019) Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart (British Cardiac Society) 105(3):235\u2013242","journal-title":"Heart (British Cardiac Society)"},{"issue":"4","key":"2586_CR33","first-page":"3","volume":"12","author":"M Khan","year":"2017","unstructured":"Khan M (2017) New oral anticoagulants (noacs) for cerebral venous thrombosis. Pak J Neurol Sci (PJNS) 12(4):3\u20134","journal-title":"Pak J Neurol Sci (PJNS)"},{"issue":"1","key":"2586_CR34","doi-asserted-by":"publisher","first-page":"22300","DOI":"10.1038\/s41598-020-78570-1","volume":"10","author":"XB Guo","year":"2020","unstructured":"Guo XB, Liu S, Guan S (2020) The clinical analysis and treatment strategy of endovascular treatment for cerebral venous sinus thrombosis combined with intracerebral hemorrhage. Sci Rep 10(1):22300","journal-title":"Sci Rep"},{"issue":"12","key":"2586_CR35","doi-asserted-by":"publisher","first-page":"105291","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105291","volume":"29","author":"S Salehi Omran","year":"2020","unstructured":"Salehi Omran S, Parikh NS, Zambrano Espinoza M, Lerario MP, Levine SR, Kamel H, Marshall R, Willey J (2020) Managing ischemic stroke in patients already on anticoagulation for atrial fibrillation: a nationwide practice survey. J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc 29(12):105291","journal-title":"J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc"},{"issue":"12","key":"2586_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1212\/WNL.0000000000001817","volume":"85","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Kamel H, Elkind MS (2015) Potential new uses of non\u2013vitamin K antagonist oral anticoagulants to treat and prevent stroke. Neurology 85(12):1078\u20131084","journal-title":"Neurology"},{"issue":"2","key":"2586_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5853\/jos.2019.00150","volume":"21","author":"M Wasay","year":"2019","unstructured":"Wasay M, Khan M, Rajput HM, Farooq S, Memon MI, AlRukn SA, Malik A, Abd-Allah F, Shoaib RF, Shahid R et al (2019) New oral anticoagulants versus warfarin for cerebral venous thrombosis: a multi-center. Obs Study J Stroke 21(2):220\u2013223","journal-title":"Obs Study J Stroke"},{"issue":"10","key":"2586_CR38","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","volume":"46","author":"R von Kummer","year":"2015","unstructured":"von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CB, Marquering HA, Mazya MV et al (2015) The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46(10):2981\u20132986","journal-title":"Stroke"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02586-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-024-02586-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02586-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:05:06Z","timestamp":1733223906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-024-02586-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1007\/s13760-024-02586-x","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were carried out with the approval of the Ethics Committee of Tabriz University of Medical Sciences (IR.TBZMED.REC.1402.240).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate."}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}